These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 15812216
1. Glucose transporter-1 expression in urothelial papilloma of the bladder. Lee JH, Kim YW, Chang SG. Urol Int; 2005; 74(3):268-71. PubMed ID: 15812216 [Abstract] [Full Text] [Related]
6. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Jones TD, Zhang S, Lopez-Beltran A, Eble JN, Sung MT, MacLennan GT, Montironi R, Tan PH, Zheng S, Baldridge LA, Cheng L. Am J Surg Pathol; 2007 Dec 15; 31(12):1861-7. PubMed ID: 18043040 [Abstract] [Full Text] [Related]
7. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Lane Z, Epstein JI. Am J Surg Pathol; 2008 May 15; 32(5):758-64. PubMed ID: 18379418 [Abstract] [Full Text] [Related]
10. Urothelial papilloma of the bladder: a review of 34 de novo cases. Magi-Galluzzi C, Epstein JI. Am J Surg Pathol; 2004 Dec 15; 28(12):1615-20. PubMed ID: 15577681 [Abstract] [Full Text] [Related]
11. Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma. Boyaci C, Behzatoğlu K. Turk Patoloji Derg; 2019 Dec 15; 35(1):22-27. PubMed ID: 30035295 [Abstract] [Full Text] [Related]
13. Frequent FGFR3 mutations in urothelial papilloma. van Rhijn BW, Montironi R, Zwarthoff EC, Jöbsis AC, van der Kwast TH. J Pathol; 2002 Oct 15; 198(2):245-51. PubMed ID: 12237885 [Abstract] [Full Text] [Related]
14. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC, Chang YH, Pan CC. Am J Surg Pathol; 2012 Mar 15; 36(3):454-61. PubMed ID: 22261706 [Abstract] [Full Text] [Related]
15. [Urothelial carcinoma with an inverted growth pattern: a report of 4 cases]. Dzombeta T, Krajacić-Jagarcec G, Tomas D, Kraus O, Ruzić B, Kruslin B. Acta Med Croatica; 2010 Mar 15; 64(1):47-50. PubMed ID: 20653125 [Abstract] [Full Text] [Related]
16. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A, Amin MB, Oliveira PS, Montironi R, Algaba F, McKenney JK, de Torres I, Mazerolles C, Wang M, Cheng L. Am J Surg Pathol; 2010 Mar 15; 34(3):371-6. PubMed ID: 20139762 [Abstract] [Full Text] [Related]
17. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Desai S, Lim SD, Jimenez RE, Chun T, Keane TE, McKenney JK, Zavala-Pompa A, Cohen C, Young RH, Amin MB. Mod Pathol; 2000 Dec 15; 13(12):1315-23. PubMed ID: 11144928 [Abstract] [Full Text] [Related]
18. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases. Leroy X, Gonzalez S, Zini L, Aubert S. Am J Surg Pathol; 2007 May 15; 31(5):770-3. PubMed ID: 17460462 [Abstract] [Full Text] [Related]
19. [Clinical studies of inverted papilloma of the bladder]. Hirasawa T, Umemoto S, Fujinami K, Senga Y, Gotou A, Asakura T. Hinyokika Kiyo; 2012 Sep 15; 58(9):471-4. PubMed ID: 23070384 [Abstract] [Full Text] [Related]